An asymmetric total synthesis of ent-sandaracopimaradiene, a biosynthetic intermediate of oryzalexins, via B-alkyl Suzuki-Miyaura coupling and Lewis acidmediated B-ring formation as key steps was achieved.
The low-molecular-weight antibiotics biosynthesized after exposure to the invader are called phytoalexins. The major phytoalexin family from the rice plant, Oryza sativa L., is diterpenes such as momilactones A and B, 2, 3) oryzalexins A-F, [4] [5] [6] [7] oryzalexin S 8) and phytocassanes A-E, 9, 10) which are commonly biosynthesized from geranylgeranyl diphosphate (GGDP, 1) (Fig. 1) . The proposed biosynthetic pathways from GGDP (1) to the diterpenoid phytoalexins involve three major steps. The first step of biosynthesis is the cyclization of GGDP to ent-or syn-copalyl diphosphate (CDP, 2 and 3), 11) and the second step is cyclization of the resulting CDPs to such tri-or tetra-cyclic hydrocarbons as ent-sandaracopimaradiene (4), 12) ent-cassa-12,15-diene (5), 13) 9-pimara-7,15-diene (6) 12, 14) and stemar-13-ene (7).
13)
The final step for phytoalexins should be the oxidation of the hydrocarbons to introduce hydroxyl and/or carbonyl functionalities. A considerable number of studies have been conducted on the identification of the genes encoding the enzymes of the cyclization reactions, and all of the genes have been identified. 13, [15] [16] [17] [18] [19] [20] The synthetic organic chemistry was a powerful tool in these studies for providing an authentic sample to identify ent-cassa-12,15-diene synthase [OsKS7 (OsDTC1)], because ent-cassa-12,15-diene was a novel compound and not available from any other natural sources. 21) The missing rings in the biosynthetic pathways of the phytoalexins are oxidation steps. Namely, no oxidase has been identified, except for a dehydrogenase which catalyzed the oxidation of 8 to momilactone A. 22) In order to identify the oxygenases that catalyze oxidation of the hydrocarbons, the substrates for enzymatic oxidation will be needed. However, a sufficient amount of the hydrocarbons is not available from natural sources. Although the syntheses of (AE)-4 23, 24) and (À)-4 25, 26) have been reported, the synthesis of (+)-4 has not been reported. We therefore decided to develop a new method for the synthesis of (+)-4 to provide a sample for studies on the identification of the oxidases. This paper describes an asymmetric total synthesis of entsandaracopimaradiene [(+)-4], a putative biosynthetic precursor of oryzalexins A-F, via B-alkyl SuzukiMiyaura coupling 27) and Lewis acid-mediated B-ring formation as the key steps.
Results and Discussion
We have already reported the synthesis of ent-cassa-12,15-diene (5) from optically active Wieland-Miescher ketone as a starting material, 21) but the synthetic sequence was very lengthy. We therefore decided to develop a more efficient method for the synthesis of optically active tricyclic diterpenoids. We have recently reported a novel method for the synthesis of abietane diterpenoids via B-alkyl Suzuki-Miyaura coupling as the key step. 28) This method would be applicable to the synthesis of ent-sandaracopimaradiene (4). Scheme 1 summarizes our synthetic plan for ent-sandaracopimaradiene (4). Precursor aldehyde A 23, 24) was synthesized from key tricyclic compound B. Enone B was synthesized via the Lewis acid-mediated cationic cyclization of C which had been synthesized by B-alkyl Suzuki-Miyaura coupling of optically active -cyclohomogeranyl iodide (E) and an aryl unit (D).
Scheme 2 shows the asymmetric synthesis of key tricyclic intermediate (À)-14. The starting material, optically active (99% e.e.) -cyclohomogeranyl iodide (9 = E), was prepared by the known procedure via enzymatic asymmetric hydrolysis. 29, 30) B-Alkyl Suzuki-Miyaura coupling of 9 with 10 (= D) 31) under the established condition 28) gave 11 (= C) in a 76% yield. Lewis acid-mediated cyclization of 11 according to Ishihara's procedure 32) gave tricyclic 12 in a 99% yield. The acetyl group of 12 was removed by alkaline hydrolysis, and then the resulting hydroxyl group was methylated to give 13. Birch reduction of 13 and an acidic work-up gave (À)-podocarpa-8(14)-en-13-one 14 (= B). Unfortunately, an HPLC analysis of 14 with a chiral stationary phase revealed the enantiomeric purity of 14 to be 80% e.e. Since the enantiomeric purity of starting material 9 was 99% e.e., this result indicates that the partial racemization had occurred in the Lewis acidmediated B-ring closing reaction. Matsumoto and Usui have reported a similar result in their synthesis of (+)-
14.
33) Fortunately, the diminished enantiomeric purity of the synthetic intermediate was retrieved by simple recrystallization. The recrystallization of 13 (80% e.e.) from MeOH and of 14 (80% e.e.) from hexane gave good crystals with 89.2% e.e. and 89.9% e.e. respectively. Finally, enantiomerically pure (99.6% e.e.) 14 was obtained through the two recrystallizations. Enone 14 is a useful synthetic intermediate of various terpenoids. 34) Optically active (+)-14 has been prepared by converting from natural occurring terpenoids such as manool 35, 36) or abietic acid 37) and by asymmetric syntheses. 28, 33, 38) On the other hand, only one synthesis of optically pure (À)-14 from eperuic acid has been reported. 39) However, this is not a convenient procedure due to the fact that eperuic acid is a rare terpenoid, so Synthesis of ent-Sandaracopimaradieneour procedure provides the first practical method for the synthesis of (À)-14.
With key tricyclic intermediate (À)-14 in hand, the target compound, ent-sandaracopimaradiene (4), was synthesized (Scheme 3). Synthetic studies were conducted with (À)-14 and easily available (AE)-14. Birch reduction of enone 14 gave a lithium enolate with a trans-anti-trans-ring juncture, and triflation of the resulting enolate with Comins' reagent 40) gave enol triflate 15 with an isomer of the double bond. However, this mixture was employed in the next step without purification due to the difficulty in separation and the instability of 15. Palladium-catalyzed methoxy carbonylation 41) and reduction of the resulting ester by DIBAL gave allylic alcohol 16. The undesired olefinic isomer was separated at this stage. The overall yield of 16 from enone 14 was 74% in 3 steps. After Dess-Martin oxidation 42) of alcohol 16 (81%), resulting enal 17 was treated with t-BuOK and MeI in refluxing benzene under the reported condition 23, 24) to give a diastereomeric mixture of 18a and 18b in a 78% yield. After separating by MPLC, the relative stereochemistry of 18a and 18b was determined by comparing the 1 H-NMR spectra with those of the related compounds.
43) The ratio of diastereomers was estimated to be 2:1 by the 1 H-NMR analysis. A Wittig reaction of 18a with methylene triphenylphosphorane gave ent-sandaracopimaradiene 
The physical properties were in good accordance with those of the reported data 44, 45) of (À)-4. Since the obtained (+)-4 was confirmed to be pure by NMR analyses and there was no possibility of any racemization of the synthetic intermediates, the slight difference in the absolute value of ½ D might have originated from the difference in concentration. The overall yield of (+)-4 was 2.6% from 9 in 12 steps.
Conclusion
We developed a novel procedure for the asymmetric synthesis of ent-sandaracopimaradiene [(+) -4] . The key steps of our synthesis were B-alkyl Suzuki-Miyaura coupling and Lewis acid-mediated cationic B-ring closure. Although racemization in the B-ring closure reaction was observed, the optically pure tricyclic enone (14) was obtained by recrystallization. Since enone 14 is a useful synthetic intermediate for the synthesis of various diterpenoids, this synthesis is a novel formal asymmetric synthesis of such diterpenoids. A synthetic sample of ent-sandaracopimaradiene [(+)-4] will be provided for studies on the biosynthesis of oryzalexins.
Experimental
All melting point (mp) data are uncorrected. Optical rotation values were recorded with a Jasco DIP-140 instrument, and IR spectra were measured with a Shimadzu IR-470 spectrometer. NMR spectra were recorded with a Jeol JNM-A400 spectrometer operated at 400 MHz for 1 H-NMR spectra and 100 MHz for 13 C-NMR spectra. Chemical shifts are reported as ppm relative to CHCl 3 measured from the solvent resonance (7.24 ppm). Elemental compositions were analyzed by a J-Science JM10 MICROCORDER. HPLC analyses were carried out by using a Jasco PU-880 pump and a Jasco UV-2075 detector. Column chromatography was carried out with silica gel (Wakogel C-200). (11) . To a stirred solution of 9 (4.53 g, 16.3 mmol) in dry ether (70 ml) was added dropwise 1.59 M t-BuLi in pentane (22.5 ml, 35.8 mmol) at À78 C under an Ar atmosphere. After stirring for 15 min, 1.0 M Bmethoxy-9-BBN in hexane (37.5 ml, 37.5 mmol) and dry THF (45 ml) were successively added. The mixture was allowed to warm to room temperature for 80 min. To the warmed mixture, 3 M K 3 PO 4 (10.9 ml, 32.7 mmol), a solution of 10 (4.27 g, 16.3 mmol) in dry DMF (40 ml) and Pd(PPh 3 ) 4 (941 mg, 0.82 mmol) were successively added. The mixture was refluxed for 100 min at 80 C. After cooling to room temperature, the cooled mixture was poured into water. The aqueous phase was extracted with ether, and the combined organic phases were washed with brine and dried over MgSO 4 . The solvent was evaporated and the residue was purified by column chromatography with SiO 2 (hexane/EtOAc = 80:1) to give 11 as a colorless oil (3.53 g, 76%).
Properties of (R) (5R,10R)-13-Acetoxypodocarpa-8,11,13-triene (12) . To a stirred solution of 11 (3.14 g, 11.0 mmol) in dry MeNO 2 (95 ml) was added dropwise BF 3 -OEt 2 (5.56 ml, 43.9 mmol) at 0 C under an Ar atmosphere. After stirring for 2.5 h at the same temperature, the mixture was poured into sat. aq. NaHCO 3 . The aqueous phase was extracted with ether. The combined extracts were washed with water and sat. aq. NaHCO 3 , and dried with MgSO 4 . The solvent was evaporated and the residue was purified by column chromatography with SiO 2 (hexane/ EtOAc = 50:1) to give 12 as a colorless oil (3.11 g, 99%).
Properties of (5R, (5R,10R)-13-Methoxypodocarpa-8,11,13-triene (13) . To a stirred solution of 12 (1.41 g, 4.93 mmol) in MeOH (20 ml) was added K 2 CO 3 (2.04 g, 14.8 mmol) at room temperature. After stirring for 1 h at the same temperature, the mixture was poured into water. The aqueous phase was extracted with ether. The separated aqueous phase was acidified with dil. HCl and extracted with ether. The combined organic phases were washed with brine and dried with MgSO 4 . The solvent was evaporated to give a crude material (1.19 g). The resulting residue was dissolved in EtOH (15 ml). To this solution were successively added Me 2 SO 4 (934 ml, 9.86 mmol) and NaOH (394 mg, 9.86 mmol). The reaction mixture was stirred for 30 min at 60 C. After cooling to room temperature, the solvent was removed by evaporation. The residue was diluted with hexane and water. The aqueous phase was extracted with hexane. The combined organic phases were successively washed with water and brine, and dried with MgSO 4 . The solvent was removed by evaporation, and the residue was purified by column chromatography with SiO 2 (hexane/EtOAc = 80:1) to give 13 (1.22 g, 96%). Recrystallization from MeOH gave colorless plates (82%, 89.2% e.e.). The enantiomeric purity of the obtained plates was determined after converting 13 into 14.
Properties of (5R, (5R,9R,10R)-Podocarp-8(14)-en-13-one (14) . A solution of 13 (740 mg, 2.87 mmol) in dry THF (100 ml) and EtOH (8 ml) was added dropwise to liq. NH 3 (100 ml) at À78 C under an Ar atmosphere. Lithium (2.50 g, 357 mmol) was added portionwise for 40 min to the solution. The solution was stirred for 70 min at À40 C. The reaction was quenched by carefully additing water and ether. After stirring overnight while gradually warming to room temperature, the mixture was poured into water. The aqueous phase was extracted with ether. The combined extracts were successively washed with water and brine, and dried with MgSO 4 . The solvent was evaporated to give a crude material (774 mg). This crude material was diluted with MeOH (15 ml), and 1 N HCl (10 ml) was added to the solution. The mixture was refluxed for 1 h, and allowed to cool to room temperature. The mixture was poured into water. The aqueous phase was extracted with ether. The combined organic phases were successively washed with water and brine, and dried with MgSO 4 . The solvent was removed by evaporation, and the residue was purified by column chromatography with SiO 2 (hexane/EtOAc = 20:1) to give (À)-14 (621 mg, 88%). Recrystallization from hexane gave colorless rods (82%). The enantiomeric purity was estimated to be 99.6% e.e. by an HPLC analysis: Daicel Chiralcel OD, hexane/i-PrOH = 50:1, flow late = 0.3 ml/min, at 0 C, t R ¼ 72:8 (5R,9R,10R) and 75.9 (5S,9S,10S).
Properties of (5R, (5R,9R,10R)-Podocarp-13(14)-en-13-methanol (16) . Lithium (98 mg, 14.2 mmol) was added portionwise at À78 C to dried liquid NH 3 (80 ml, distilled from lithium amide). The flask was purged with Ar, and the solution was stirred for 35 min. A solution of 14 (680 mg, 2.76 mmol) and aniline (252 ml, 2.76 mmol) in dry THF (15 ml) was added dropwise to the solution at the same temperature. After stirring for 20 min, freshly distilled isoprene was added dropwise until the solution turned colorless. The solvent was removed in vacuo at room temperature under a gentle Ar flow. The residue was dissolved in dry THF (10 ml), and a solution of Comins' reagent (4.34 g, 11.1 mmol) in dry THF (20 ml) was added dropwise at 0 C. After stirring for 45 min, the mixture was poured into water. The aqueous phase was extracted with hexane. The combined extracts were successively washed with water and brine, and dried with Na 2 SO 4 . The solvent was removed by evaporation, and the residue was chromatographed on SiO 2 (hexane) to give crude enol triflate 15 (906 mg). The obtained enol triflate was dissolved in MeOH (4 ml) and DMF (4 ml). To the solution were successively added Ph 3 P (60 mg, 0.23 mmol), Pd(OAc) 2 (26 mg, 0.11 mmol) and Et 3 N (635 ml, 4.56 mmol). The mixture was stirred for 9 h at room temperature under a CO atmosphere. The mixture was poured into water, and the aqueous phase was extracted with ether. The combined extracts were successively washed with water and brine, and dried with MgSO 4 . The solvent was removed by evaporation, and the residue was chromatographed on SiO 2 (hexane/ EtOAc = 250:1) to give a crude ester (593 mg). This crude ester was dissolved in dry THF (5 ml), and the solution was cooled to À78 C under Ar. To the solution was added dropwise 1.0 M DIBAL in hexane (5.11 ml, 5.11 mmol). After stirring for 45 min, the reaction was quenched by carefully adding dil. HCl. The mixture was allowed to warm to room temperature and stirred for 30 min. The aqueous phase was extracted with ether. The combined extracts were successively washed with dil. HCl, water and sat. NaHCO 3 , and dried with (5R,9R,10R)-13-Podocarp-13(14)-en-13-carboxaldehyde (17) . To a stirred solution of 16 (530 mg, 2.02 mmol) in CH 2 Cl 2 (10 ml) at 0 C was added DessMartin periodinane (1.03 g, 2.43 mmol). After stirring for 30 min at room temperature, the reaction was quenched by carefully adding sat. aq. Na 2 SO 3 and ether. After stirring for 30 min, the mixture was poured into water. The aqueous phase was extracted with ether. The combined extracts were successively washed with water and sat. aq. NaHCO 3 , and dried with Na 2 SO 4 . The solvent was evaporated and the residue was purified by column chromatography with SiO 2 (hexane/EtOAc = 200:1) to give 17 as colorless plates (425 mg, 81%). This product was employed in the next step without further purification.
Properties of (5R, (5R,9R,10R,13R)-13-Methylpodocarp-8(14)-en-13-carboxaldehyde (18a). A suspension of 17 (420 mg, 1.62 mmol) and t-BuOK (18.1 g, 162 mmol) in dry tBuOH (80 ml) and dry benzene (20 ml) was refluxed at 110-120 C for 4 min under Ar. The solution was immediately cooled to room temperature in an ice bath, and MeI (15.1 ml, 242 mmol) was added to the mixture. The suspension was cooled to 0 C and stirred for 1 h. The mixture was poured into water. The aqueous phase was extracted with ether. The combined extracts were successively washed with water and brine, and dried with Na 2 SO 4 . The solvent was evaporated and the residue was purified by column chromatography with SiO 2 (hexane/EtOAc = 600:1) to give a diastereomeric mixture (344 mg, 78%) and starting material 17 (87 mg). The ratio of the diastereomers was estimated to be 2:1 by a 1 H NMR analysis. The diastereomers were separated by MPLC (hexane/benzene = 100:1) to give 18a as a colorless waxy solid.
Properties of (5R,9R,10R,13R ent-Sandaracopimaradiene (4). To a stirred suspension of methyltriphenylphosphonium bromide (176 mg, 0.49 mmol) in dry THF (2 ml) at À78 C was added dropwise 2.64 M n-BuLi in hexane (187 ml, 0.49 mmol) under an Ar atmosphere. After stirring for 30 min at the same temperature, the mixture was added dropwise to a solution of 15 (27 mg, 0.099 mmol) in dry THF (1 ml) at 0 C under Ar. After stirring for 1 h, the mixture was poured into water. The aqueous phase was extracted with pentane. The combined extracts were successively washed with water and brine, and dried with Na 2 SO 4 . The solvent was evaporated and the residue was purified by column chromatography with SiO 2 (pentane) to give 4 as a colorless waxy solid (16 mg, 60%). 
